Skip to main content
Signal8

LYNCH TIMOTHY P

SEC insider (Form 3/4/5 filer). CIK 0001270925. 10% Owner at AEON Biopharma, Inc. (AEON). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 19, 2026. Located in BEND, OR.

Companies LYNCH TIMOTHY P has filed insider reports for

  • AEON Biopharma, Inc. (AEON): 10% Owner
LYNCH TIMOTHY P profile photo

LYNCH TIMOTHY P

CIK: 0001270925

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AEON Biopharma, Inc. logo
AEON

AEON Biopharma, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Aug 19, 2026
    Purchase
    Direct
    1.2M shares at avg. $0.21$243K

1-1 of 1